Abstract
Hyperventilation is defined as a state of alveolar ventilation in excess of metabolic requirements resulting in decreased arterial partial pressure of carbon dioxide (PaCO 2 ). When hyperventilation occurs chronically or in recurrent episodes and is associated with somatic (respiratory, neurological, intestinal) or psychological (anxiety) symptoms, the clinical entity is called hyperventilation syndrome (HVS). 1 HVS and panic disorder are strongly associated; most patients show characteristics of both disorders, but they generally lack findings of any underlying organic disease. 2 3 The correct diagnosis of HVS is of great clinical importance since at least 5-10% of general medical outpatients have been reported to suVer from this syndrome and, due to a variety of somatic symptoms, the risks of misdiagnosis are considered to be high. 4 Several diagnostic tools have been described since only few patients with HVS are actually seen during a typical attack. The reproduction of the HVS symptoms during voluntary hyperventilation has been suggested as a basis for the diagnosis, 5 but recent studies have shown that the test lacks both sensitivity and specificity. 6 Even the validity of the test has been questioned, since the symptoms in HVS often precede events of hypocapnia rather than are a consequence of them. 7 Symptoms and hyperventilation may also be provoked in susceptible patients by exercise, [8] [9] [10] mental stress, 9 and by pharmacological challenges. 11 12 In our earlier studies respiratory alkalosis in arterial blood was frequently found during orthostatic tests in patients with HVS, 8 suggesting that change in body posture provokes these patients to have abnormal ventilatory responses.
The aim of the present study was to assess the ventilatory responses of patients with HVS when changing the body position from supine to standing. We also compared these results with those of healthy subjects to evaluate whether the orthostatic changes in pulmonary gas exchange discriminate patients with HVS.
Methods
The anthropometric and lung function data of the patients and subjects are shown in table 1. Sixteen patients (eight women) with diagnosed HVS, but without signs of underlying cardio-respiratory disease, were selected for the study. The basis for the HVS diagnosis was the history of recurrent or episodic dyspnoea, air hunger, dizziness, or paraesthesiae, and the detection of respiratory alkalosis (pH >7.45 and PaCO 2 <4.7 kPa) in arterial blood during symptoms of hyperventilation. Patients with a history of physician diagnosed asthma or ischaemic heart disease, with or without regular medication, were excluded from the study. None of the patients included used any cardiorespiratory medication at the time of the study; five (31%) of the patients had previously used anxiolytic medication. All patients underwent physical examination, chest radiography, flow-volume spirometry, and cardiorespiratory exercise tests with ECG to exclude any organic cardiorespiratory disease. Bronchial hyperreactivity with histamine provocation tests 13 and pulmonary diVusing capacity were determined if clinically indicated to exclude asthma and interstitial lung disorders, respectively.
All patients complained of episodic dyspnoea or air hunger. Chest pain (19%), dizziness (31%), gastroenterological symptoms (19%), and numbness of the face or fingers (25%) were also common symptoms. In 11 patients (69%) palpitations, sweating, trembling, dryness of the mouth or other symptoms of overactivity of the autonomic nervous system were also present, suggestive of panic disorder. 14 Thirteen healthy non-smoking subjects (eight women) without any cardiorespiratory symptoms or signs volunteered as controls. They all showed normal findings in physical examination, resting ECG, and in flow-volume spirometric tests.
Informed consent was obtained from every patient and subject and the study was approved by the ethics committee of the Department of Pulmonary Medicine at Helsinki University Central Hospital.
Forced expiratory volume in one second (FEV 1 ), forced vital capacity (FVC), the ratio of FEV 1 to FVC, and the maximal expiratory flow at 50% of FVC (MEF 50 ) were determined with a rolling seal spirometer (CPI 220, Cardiopulmonary Instruments, Houston, USA) connected to a microcomputer system (Medikro 202, Kuopio, Finland), according to European recommendations. 15 The results from the envelope curve of at least three superimposed forced expiratory flow-volume loops were recorded.
The orthostatic tolerance tests were performed in a quiet, dimly lit laboratory room during oYce hours. Before orthostatic testing the brachial artery of the patient was cannulated under local anaesthesia (1% lidocaine). Thereafter, two nurses conducted the test and recordings. After the patient had rested for 10 minutes in the supine position a face mask (Rudolf series 7910, Hans Rudolf Inc, Kansas City, USA) was tightly attached and connected to an automatic gas exchange analyser with a mixing chamber (Ergo-Oxyscreen, Erich Jaeger, Würzburg, Germany). The mask and the valve system had a dead space of 185 ml. The patients were allowed to breathe via the mask in the supine position for five minutes to adapt for the increased dead space; minute ventilation (Ṽ E), breathing frequency (BF), oxygen consumption (Ṽ O 2 ), carbon dioxide outflow (Ṽ CO 2 ), respiratory exchange ratio (RQ), ventilatory equivalents for O 2 (Ṽ E/Ṽ O 2 ) and for CO 2 (Ṽ E/Ṽ CO 2 ), and end expiratory tidal CO 2 fraction (FETCO 2 ) were then recorded over a 30 second interval and an arterial blood sample for blood gas analysis (PaO 2 , PaCO 2 , pH, base excess) was simultaneously drawn via the cannula. Heart rate (HR) and blood pressure (BP) were also recorded at this stage.
After the resting period the patients were asked to rise and to stand still and unsupported in the upright body position for eight minutes. 16 During this phase the room was kept quiet and no conversation was allowed. Respiratory gas exchange and ECG (HR) were continuously monitored and, after standing for eight minutes, the blood pressure was determined and an arterial blood sample was drawn from the brachial cannula. The respiratory gas exchange results at this time were determined from the gas concentrations in the mixing chamber during the last 30 seconds in the upright body position. In healthy controls the study design was identical to that in the patients with HVS except that arterial cannulation was not performed for ethical reasons, and therefore no arterial blood samples were taken.
In paired comparisons of test results between body positions the Wilcoxon signed rank test was used, and in comparisons between study groups the Mann-Whitney U test was applied. For correlation analysis the Pearson correlation coeYcient was calculated.
Results

RESPIRATORY GAS EXCHANGE RESPONSES
The results of pulmonary gas exchange at rest and during the orthostatic test in healthy subjects and in patients with HVS are shown in table 2. The individual responses of Ṽ E, Ṽ E/Ṽ O 2 , ṼE/Ṽ CO 2 , and FETCO 2 during the orthostatic test are illustrated in figs 1, 2, 3 and 4, respectively. The resting values were not significantly diVerent between the groups. In both groups the mean FETCO 2 was within the normal range but in individual patients and subjects the FETCO 2 at rest was slightly low. During the orthostatic test the controls did not show an increase in BF but their Ṽ E increased significantly (p = 0.01). In the HVS patients both BF (p = 0.005) and Ṽ E (p = 0.001) increased sig- The sensitivity, specificity, and positive predictivity of respiratory gas exchange variables during the orthostatic tolerance test for discrimination of HVS were evaluated (table The results within groups are expressed as mean (SE) and the changes as mean (95% confidence intervals). BF = breathing frequency; Ṽ E = minute ventilation; RQ = respiratory exchange ratio; FETCO 2 = end expiratory tidal CO 2 fraction; Ṽ E/Ṽ O 2 , ṼE/Ṽ CO 2 = ventilatory equivalents for O 2 and CO 2 ; HR = heart rate; BP = blood pressure. 3). Depending on the variable chosen, the sensitivity ranged from 69% to 93% and the specificity from 77% to 100%.
Figure 1 Individual responses of minute ventilation (Ṽ E) during the orthostatic test in (A) healthy controls (n = 13) and (B) patients with HVS (n = 16). The p value refers to the Wilcoxon signed rank test.
Figure 2 Individual responses of the ventilatory equivalent for oxygen (Ṽ E/Ṽ O 2 ) during the orthostatic test in (A) healthy controls (n = 13) and (B) patients with HVS (n = 16). The p value refers to the Wilcoxon signed rank test.
ARTERIAL BLOOD GAS RESPONSES
Fourteen patients with HVS (87%) had hypocapnia (PaCO 2 <4.7 kPa) with or without respiratory alkalosis (pH >7.45) in the arterial blood while standing during the orthostatic test, indicating hyperventilation. As a response to the orthostatic test mean (SE) PaCO 2 decreased from 4.6 (0.1) kPa to 3.7 (0.2) kPa (p = 0.0006) and pH increased from 7.45 (0.01) to 7.50 (0.01) (p = 0.001).
In the patients with HVS the FETCO 2 during the standing phase correlated closely with the simultaneous PaCO 2 (r = 0.93, p<0.0001; fig 5) ; there was also a close relationship between arterial blood pH and Ṽ E/Ṽ CO 2 (r = 0.78, p = 0.0004).
CIRCULATORY RESPONSES
HR was significantly higher in the HVS group than in healthy controls both at rest (mean difference 7.9 bpm, 95% CI 1.6 to 14.2) and in the standing position (mean diVerence 16.4 bpm, 95% CI 4.8 to 27.9). The increase in HR as a response to standing up was also (table 2) .
Figure 3 Individual responses of the ventilatory equivalent for carbon dioxide (Ṽ E/Ṽ CO 2 ) during the orthostatic test in (A) healthy controls (n = 13) and (B) patients with HVS (n = 16). The p value refers to the Wilcoxon signed rank test.
Figure 4 Individual responses of end expiratory tidal CO 2 fraction (FETCO 2 ) during the orthostatic test in (A) healthy controls (n = 13) and (B) patients with HVS (n = 16). The p value refers to the Wilcoxon signed rank test.
SYMPTOMS DURING THE TEST
After the orthostatic tests the subjects and patients were asked for symptoms during the test. In the HVS group nine (56%) complained of dyspnoea, six (38%) of dizziness, three (19%) of numbness of the fingers or face, two (13%) of trembling, and one (6%) of sweating. In the healthy controls three (23%) reported dizziness but none complained of dyspnoea.
Discussion
This study shows that the change in body posture during the orthostatic test significantly increases pulmonary ventilation in excess of metabolic needs in many patients with HVS. Most of the patients with HVS showed an accentuated ventilatory response which distinguishes them from healthy controls. In HVS patients the consequent respiratory alkalosis or hypocapnia in arterial blood was closely associated with changes in non-invasive pulmonary gas exchange measurements. In our patients with an established diagnosis of HVS organic cardiorespiratory diseases were excluded to assure that, when present, the hyperventilation was not secondary to any other disease. The gas exchange and circulatory responses were not modified by any medication since the patients were not receiving any drug treatment. The healthy controls were free of cardiorespiratory symptoms and diseases and their anthropometric data did not diVer significantly from the HVS patients except for body mass index. The latter is unlikely to explain the diVerent respiratory gas exchange patterns between the groups, since obesity is not known to induce hyperventilation. The study design was not completely identical between the groups as only patients with HVS had an arterial indwelling line placed under local anaesthesia before the test. However, the gas exchange variables at rest (after 15 minutes from arterial cannulation) did not diVer between the groups, and therefore the significantly diVerent responses during the orthostatic test are unlikely to result from this intervention.
At rest in both groups some subjects showed somewhat low FETCO 2 values (fig 4) but the mean values were within normal limits (table  2) . In patients with HVS the correlation between PaCO 2 and FETCO 2 was good and the calculated mean arterial end tidal diVerence in CO 2 at rest was 0.3 kPa which is close to the expected value 17 ; we therefore think that our end tidal measurements were reliable. Due to ethical reasons we did not sample arterial blood from the healthy controls but, based on the end tidal measurements, it is probable that in some of the subjects the test conditions induced slight hyperventilation. Since the control subjects were healthy and did not have any history of respiratory symptoms, we regard their results as a normal range of ventilation during the conditions of the present study. More importantly, the ventilatory responses during standing and not the baseline values were discriminatory between our study groups. Updated information and services can be found at:
These include:
